Results 51 to 60 of about 19,110 (253)

Carotid artery stenting: a single-centre experience with up to 8 years' follow-up [PDF]

open access: yes, 2009
Carotid artery stenting (CAS) may be an alternative to surgical endoarterectomy not only in high-risk patients. We report results in the endovascular treatment of carotid artery disease with up to 8 years' follow-up.
Di Primio, M   +9 more
core   +1 more source

Impact of Proton Pump Inhibitor Use on Outcomes Following Carotid Artery Stenting for Asymptomatic Carotid Stenosis: A Population‐Based Cohort Study

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Carotid artery stenting (CAS) is an effective treatment for carotid stenosis. Proton‐pump inhibitors (PPIs) are commonly prescribed in the general population. However, the impact of PPI use on outcomes following CAS remains unknown. This study investigated the impact of PPI use on CAS using a retrospective, matched‐cohort analysis from the ...
Chia‐En Wong   +7 more
wiley   +1 more source

Carotid endarterectomy in Russia. What if current guidelines do not answer difficult questions?

open access: yesРоссийский кардиологический журнал, 2023
This literature review covers the publications of Russian vascular surgeons in recent years and deals with debatable issues of carotid surgery, including: 1. What is the best technique for carotid endarterectomy (CEA)? 2.
A. V. Sukhareva   +15 more
doaj   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo   +22 more
wiley   +1 more source

Tratamento endovascular da reestenose carotídea: resultados em curto prazo Endovascular treatment of carotid artery restenosis: short term results

open access: yesJornal Vascular Brasileiro, 2011
CONTEXTO: O tratamento cirúrgico da reestenose carotídea apresenta alta taxa de lesão neurológica. Contrariamente, o tratamento endovascular da doença obstrutiva carotídea extracraniana tem se tornado mais factível e gradualmente menores taxas de risco ...
Ricardo Augusto Carvalho Lujan   +4 more
doaj   +1 more source

Single-Center Experience With Carotid Stent Restenosis

open access: yesJournal of Endovascular Therapy, 2002
Purpose: To report the angiographic morphology of carotid stent restenosis and the possible therapies based on data from a single-center experience. Methods: In a 45-month period, 279 patients (196 men; mean age 70 ± 9 years, range 50–89) underwent successful Wallstent placement in 303 stenotic internal carotid arteries (ICA).
Andrea, Willfort-Ehringer   +5 more
openaire   +2 more sources

Severe Supravalvular Aortic Stenosis Treated With Double Patch Aortoplasty: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Severe supravalvular aortic stenosis in a young patient is a rare but critical condition requiring timely diagnosis and intervention. We report a 15‐year‐old girl presenting with exertional dyspnea, chest pain, and palpitations. Echocardiography and multidetector computed tomography (MDCT) confirmed severe supravalvular aortic stenosis ...
Birat Kadel   +4 more
wiley   +1 more source

Pre-procedural C-reactive protein levels and carotid or intracranial artery restenosis: A systematic review and meta-analysis

open access: yesAtherosclerosis Plus
Introduction: Restenosis of the carotid or intracranial (IC) arteries, shown to be associated with increased risk of ischemic stroke, represents an unresolved clinical issue.
Krishi Jain   +8 more
doaj   +1 more source

MAPK phosphorylation of connexin 43 promotes binding of cyclin E and smooth muscle cell proliferation

open access: yes, 2012
<p>Rationale: Dedifferentiation of vascular smooth muscle cells (VSMC) leading to a proliferative cell phenotype significantly contributes to the development of atherosclerosis.
Best, A.K.   +12 more
core   +1 more source

Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]

open access: yes, 2011
<p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H.   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy